<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p81" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_81{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_81{left:341px;bottom:30px;}
#t3_81{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_81{left:377px;bottom:30px;}
#t5_81{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_81{left:540px;bottom:30px;}
#t7_81{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_81{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_81{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_81{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_81{left:285px;bottom:827px;letter-spacing:-0.37px;word-spacing:0.11px;}
#tc_81{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_81{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_81{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_81{left:1119px;bottom:28px;letter-spacing:0.3px;}
#tg_81{left:36px;bottom:166px;}
#th_81{left:42px;bottom:160px;letter-spacing:0.12px;word-spacing:-0.06px;}
#ti_81{left:317px;bottom:160px;}
#tj_81{left:36px;bottom:149px;}
#tk_81{left:50px;bottom:143px;letter-spacing:0.13px;}
#tl_81{left:36px;bottom:132px;}
#tm_81{left:46px;bottom:126px;letter-spacing:0.12px;}
#tn_81{left:36px;bottom:115px;}
#to_81{left:46px;bottom:109px;letter-spacing:0.13px;}
#tp_81{left:261px;bottom:109px;}
#tq_81{left:36px;bottom:778px;letter-spacing:0.43px;word-spacing:-0.26px;}
#tr_81{left:357px;bottom:778px;letter-spacing:0.3px;}
#ts_81{left:465px;bottom:786px;}
#tt_81{left:35px;bottom:592px;letter-spacing:-0.09px;}
#tu_81{left:35px;bottom:573px;letter-spacing:-0.08px;}
#tv_81{left:35px;bottom:555px;letter-spacing:-0.17px;}
#tw_81{left:35px;bottom:537px;letter-spacing:-0.09px;}
#tx_81{left:36px;bottom:359px;letter-spacing:-0.09px;}
#ty_81{left:36px;bottom:340px;letter-spacing:-0.09px;}
#tz_81{left:36px;bottom:322px;letter-spacing:-0.1px;}
#t10_81{left:81px;bottom:330px;}
#t11_81{left:187px;bottom:616px;letter-spacing:-0.09px;}
#t12_81{left:187px;bottom:504px;letter-spacing:-0.09px;}
#t13_81{left:177px;bottom:385px;letter-spacing:-0.09px;}
#t14_81{left:177px;bottom:290px;letter-spacing:-0.09px;}
#t15_81{left:357px;bottom:689px;letter-spacing:-0.09px;}
#t16_81{left:357px;bottom:670px;letter-spacing:-0.09px;}
#t17_81{left:357px;bottom:652px;letter-spacing:-0.09px;}
#t18_81{left:357px;bottom:634px;letter-spacing:-0.1px;}
#t19_81{left:497px;bottom:641px;}
#t1a_81{left:357px;bottom:615px;letter-spacing:-0.09px;}
#t1b_81{left:357px;bottom:597px;letter-spacing:-0.09px;}
#t1c_81{left:357px;bottom:579px;letter-spacing:-0.11px;}
#t1d_81{left:357px;bottom:514px;letter-spacing:-0.09px;}
#t1e_81{left:357px;bottom:495px;letter-spacing:-0.1px;}
#t1f_81{left:440px;bottom:503px;}
#t1g_81{left:357px;bottom:395px;letter-spacing:-0.1px;}
#t1h_81{left:357px;bottom:377px;letter-spacing:-0.1px;}
#t1i_81{left:431px;bottom:384px;}
#t1j_81{left:357px;bottom:321px;letter-spacing:-0.1px;}
#t1k_81{left:357px;bottom:302px;letter-spacing:-0.09px;}
#t1l_81{left:357px;bottom:284px;letter-spacing:-0.1px;}
#t1m_81{left:357px;bottom:266px;letter-spacing:-0.1px;}
#t1n_81{left:440px;bottom:273px;}
#t1o_81{left:561px;bottom:659px;letter-spacing:-0.1px;}
#t1p_81{left:561px;bottom:640px;letter-spacing:-0.1px;}
#t1q_81{left:561px;bottom:329px;letter-spacing:-0.09px;}
#t1r_81{left:561px;bottom:311px;letter-spacing:-0.09px;}
#t1s_81{left:561px;bottom:293px;letter-spacing:-0.26px;}
#t1t_81{left:723px;bottom:745px;letter-spacing:-0.1px;}
#t1u_81{left:723px;bottom:727px;letter-spacing:-0.09px;}
#t1v_81{left:723px;bottom:708px;letter-spacing:-0.09px;}
#t1w_81{left:726px;bottom:648px;letter-spacing:-0.1px;}
#t1x_81{left:726px;bottom:602px;letter-spacing:-0.1px;}
#t1y_81{left:726px;bottom:584px;letter-spacing:-0.09px;}
#t1z_81{left:726px;bottom:566px;letter-spacing:-0.09px;}
#t20_81{left:726px;bottom:547px;letter-spacing:-0.09px;}
#t21_81{left:726px;bottom:529px;letter-spacing:-0.14px;word-spacing:0.03px;}
#t22_81{left:726px;bottom:511px;letter-spacing:-0.12px;word-spacing:0.02px;}
#t23_81{left:726px;bottom:492px;letter-spacing:-0.1px;}
#t24_81{left:853px;bottom:745px;letter-spacing:-0.1px;}
#t25_81{left:853px;bottom:727px;letter-spacing:-0.09px;}
#t26_81{left:1050px;bottom:765px;letter-spacing:-0.09px;}
#t27_81{left:1050px;bottom:747px;letter-spacing:-0.08px;}
#t28_81{left:1050px;bottom:729px;letter-spacing:-0.1px;}
#t29_81{left:1050px;bottom:710px;letter-spacing:-0.09px;}
#t2a_81{left:1050px;bottom:659px;letter-spacing:-0.13px;}
#t2b_81{left:1072px;bottom:666px;}
#t2c_81{left:1050px;bottom:593px;letter-spacing:-0.1px;}
#t2d_81{left:1149px;bottom:601px;}
#t2e_81{left:1050px;bottom:575px;letter-spacing:-0.09px;}
#t2f_81{left:1050px;bottom:556px;letter-spacing:-0.06px;}
#t2g_81{left:1050px;bottom:538px;letter-spacing:-0.09px;}
#t2h_81{left:1050px;bottom:520px;letter-spacing:-0.09px;}
#t2i_81{left:1050px;bottom:501px;letter-spacing:-0.1px;}
#t2j_81{left:727px;bottom:379px;letter-spacing:-0.1px;}
#t2k_81{left:812px;bottom:386px;}
#t2l_81{left:727px;bottom:361px;letter-spacing:-0.09px;}
#t2m_81{left:727px;bottom:264px;letter-spacing:-0.09px;}
#t2n_81{left:727px;bottom:246px;letter-spacing:-0.09px;}
#t2o_81{left:1051px;bottom:292px;letter-spacing:-0.1px;}
#t2p_81{left:1154px;bottom:299px;}
#t2q_81{left:1051px;bottom:274px;letter-spacing:-0.06px;}
#t2r_81{left:1051px;bottom:255px;letter-spacing:-0.09px;}
#t2s_81{left:1051px;bottom:237px;letter-spacing:-0.09px;}
#t2t_81{left:1051px;bottom:218px;letter-spacing:-0.1px;}
#t2u_81{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_81{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_81{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_81{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_81{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_81{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_81{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_81{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_81{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_81{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_81{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sa_81{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_81{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_81{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sd_81{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts81" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg81Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg81" style="-webkit-user-select: none;"><object width="1210" height="935" data="81/81.svg" type="image/svg+xml" id="pdf81" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_81" class="t s0_81">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_81" class="t s1_81">® </span>
<span id="t3_81" class="t s0_81">(NCCN </span>
<span id="t4_81" class="t s1_81">® </span>
<span id="t5_81" class="t s0_81">), All rights reserved. NCCN Guidelines </span>
<span id="t6_81" class="t s1_81">® </span>
<span id="t7_81" class="t s0_81">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_81" class="t s2_81">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_81" class="t s2_81">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_81" class="t s3_81">NCCN Guidelines Version 4.2024 </span>
<span id="tb_81" class="t s3_81">Salivary Gland Tumors </span>
<span id="tc_81" class="t s4_81">NCCN Guidelines Index </span>
<span id="td_81" class="t s4_81">Table of Contents </span>
<span id="te_81" class="t s4_81">Discussion </span>
<span id="tf_81" class="t s5_81">SALI-3 </span>
<span id="tg_81" class="t s6_81">l </span>
<span id="th_81" class="t s7_81">Principles of Radiation Therapy (SALI-A)</span><span id="ti_81" class="t s8_81">. </span>
<span id="tj_81" class="t s6_81">m </span>
<span id="tk_81" class="t s8_81">For submandibular and sublingual gland tumors, complete gland and tumor resection is recommended. </span>
<span id="tl_81" class="t s6_81">n </span>
<span id="tm_81" class="t s9_81">The facial nerve should be preserved if possible; strongly consider referral to a specialized center with reconstructive expertise. </span>
<span id="tn_81" class="t s6_81">o </span>
<span id="to_81" class="t s7_81">Principles of Surgery (SURG-A)</span><span id="tp_81" class="t s8_81">. </span>
<span id="tq_81" class="t s5_81">CANCER SITE </span><span id="tr_81" class="t s5_81">TREATMENT </span>
<span id="ts_81" class="t sa_81">n </span>
<span id="tt_81" class="t s5_81">Major salivary </span>
<span id="tu_81" class="t s5_81">gland (parotid, </span>
<span id="tv_81" class="t s5_81">submandibular, </span>
<span id="tw_81" class="t s5_81">sublingual) </span>
<span id="tx_81" class="t s5_81">Minor </span>
<span id="ty_81" class="t s5_81">salivary </span>
<span id="tz_81" class="t s5_81">gland </span>
<span id="t10_81" class="t sa_81">m </span>
<span id="t11_81" class="t s5_81">Clinical N0 </span>
<span id="t12_81" class="t s5_81">Clinical N+ </span>
<span id="t13_81" class="t s5_81">Clinical N0 </span>
<span id="t14_81" class="t s5_81">Clinical N+ </span>
<span id="t15_81" class="t s5_81">Surgery with </span>
<span id="t16_81" class="t s5_81">complete </span>
<span id="t17_81" class="t s5_81">resection of tumor </span>
<span id="t18_81" class="t s5_81">± neck dissection </span>
<span id="t19_81" class="t sa_81">o </span>
<span id="t1a_81" class="t s5_81">for high-grade </span>
<span id="t1b_81" class="t s5_81">and/or T3–4 </span>
<span id="t1c_81" class="t s5_81">tumors </span>
<span id="t1d_81" class="t s5_81">Surgery + neck </span>
<span id="t1e_81" class="t s5_81">dissection </span>
<span id="t1f_81" class="t sa_81">o </span>
<span id="t1g_81" class="t s5_81">Complete tumor </span>
<span id="t1h_81" class="t s5_81">resection </span>
<span id="t1i_81" class="t sa_81">o </span>
<span id="t1j_81" class="t s5_81">Complete tumor </span>
<span id="t1k_81" class="t s5_81">resection and </span>
<span id="t1l_81" class="t s5_81">lymph node </span>
<span id="t1m_81" class="t s5_81">dissection </span>
<span id="t1n_81" class="t sa_81">o </span>
<span id="t1o_81" class="t s5_81">Completely </span>
<span id="t1p_81" class="t s5_81">resected </span>
<span id="t1q_81" class="t s5_81">Incompletely </span>
<span id="t1r_81" class="t s5_81">resected, gross </span>
<span id="t1s_81" class="t s5_81">residual disease </span>
<span id="t1t_81" class="t s5_81">No adverse </span>
<span id="t1u_81" class="t s5_81">pathologic </span>
<span id="t1v_81" class="t s5_81">features </span>
<span id="t1w_81" class="t s5_81">Adenoid cystic </span>
<span id="t1x_81" class="t s5_81">Adverse pathologic features: </span>
<span id="t1y_81" class="t s5_81">• Intermediate or high grade </span>
<span id="t1z_81" class="t s5_81">• Close or positive margins </span>
<span id="t20_81" class="t s5_81">• Neural/perineural invasion </span>
<span id="t21_81" class="t s5_81">• Lymph node metastases </span>
<span id="t22_81" class="t s5_81">• Lymphatic/vascular invasion </span>
<span id="t23_81" class="t s5_81">• T3–4a tumors </span>
<span id="t24_81" class="t s5_81">Follow-up </span>
<span id="t25_81" class="t sb_81">(FOLL-A, 1 of 2) </span>
<span id="t26_81" class="t s5_81">Recurrent </span>
<span id="t27_81" class="t s5_81">or Persistent </span>
<span id="t28_81" class="t s5_81">Disease </span>
<span id="t29_81" class="t sb_81">(SALI-4) </span>
<span id="t2a_81" class="t s5_81">RT </span>
<span id="t2b_81" class="t sa_81">l </span>
<span id="t2c_81" class="t s5_81">Adjuvant RT </span>
<span id="t2d_81" class="t sa_81">l </span>
<span id="t2e_81" class="t s5_81">(preferred) </span>
<span id="t2f_81" class="t s5_81">or </span>
<span id="t2g_81" class="t s5_81">Systemic </span>
<span id="t2h_81" class="t s5_81">therapy/RT </span>
<span id="t2i_81" class="t s5_81">(category 2B) </span>
<span id="t2j_81" class="t s5_81">Resection, </span>
<span id="t2k_81" class="t sa_81">o </span>
<span id="t2l_81" class="t s5_81">if possible </span>
<span id="t2m_81" class="t s5_81">No further </span>
<span id="t2n_81" class="t s5_81">resection possible </span>
<span id="t2o_81" class="t sc_81" data-mappings='[[2,"fi"]]'>Deﬁnitive RT </span>
<span id="t2p_81" class="t sa_81">l </span>
<span id="t2q_81" class="t s5_81">or </span>
<span id="t2r_81" class="t s5_81">Systemic </span>
<span id="t2s_81" class="t s5_81">therapy/RT </span>
<span id="t2t_81" class="t s5_81">(category 2B) </span>
<span id="t2u_81" class="t sd_81">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
